Clinical Trials
4 trialsNCT03555422 2026-04-13
ENGOT-EN5
Karyopharm Therapeutics Inc
Phase 3 Completed
NCT07281599 2026-02-02
EQUIP
Qurasense
Phase NA Recruiting
NCT06815939 2026-01-29
OPTICS
DL Analytics
Phase NA Recruiting
NCT06463028 2025-12-24
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
Faeth Therapeutics
Phase 2 Recruiting